MALVERN, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $PHAS #PhaseBio–PhaseBio Doses First Patients in Canada as part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.